U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07736638) titled 'A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants' on July 27.
Brief Summary: The objective of this study is to assess the pharmacokinetic (PK), immunogenicity, safety, and tolerability of ABBV-859 after single ascending doses in healthy adult volunteers.
Study Start Date: July 28
Study Type: INTERVENTIONAL
Condition:
Healthy Volunteer
Intervention:
DRUG: ABBV-859
Oral Tablet
DRUG: Placebo for ABBV-859
Oral Tablet
DRUG: ABBV-859
Intravenous (IV) Infusion
DRUG: Placebo for ABBV-859
Intravenous (IV) Infusion
Recruitment Status: NOT_Y...